Edition:
India

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

8.69USD
6 Dec 2019
Change (% chg)

-- (--)
Prev Close
$8.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
23,388
52-wk High
$18.50
52-wk Low
$3.44

Latest Key Developments (Source: Significant Developments)

DarioHealth Reports Third Quarter Loss of $0.6 Per Share
Monday, 28 Oct 2019 

Oct 28 (Reuters) - DarioHealth Corp ::DARIOHEALTH REPORTS RESULTS FOR THIRD QUARTER 2019.Q3 REVENUE FELL 0.6 PERCENT TO $1.87 MILLION.QTRLY BASIC AND DILUTED LOSS PER SHARE $0.06.AS OF SEPTEMBER 30, 2019, CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $4.6 MILLION.NON-GAAP BILLINGS FOR THREE MONTHS ENDED SEPTEMBER 30, 2019 WERE $1.78 MILLION, A 20% DECREASE FROM $2.2 MILLION.  Full Article

Dance Biopharm Partners With DarioHealth To Expand Access To Digital Therapeutics Platform For Patients With Chronic Diseases
Wednesday, 11 Sep 2019 

Sept 11 (Reuters) - DarioHealth Corp , Dance Biopharm Holdings::DANCE BIOPHARM PARTNERS WITH DARIOHEALTH TO EXPAND ACCESS TO DIGITAL THERAPEUTICS PLATFORM FOR PATIENTS WITH CHRONIC DISEASES.DARIOHEALTH CORP - DANCE BIOPHARM SIGNS AN AGREEMENT WITH DARIOHEALTH TO INTEGRATE DANCE'S GENTLE MIST SMART INHALER INTO DARIOHEALTH'S PLATFORM.DARIOHEALTH CORP - DARIO WILL IMMEDIATELY START DESIGN OF INTEGRATED SOLUTION FOR DANCE TO ACCOMMODATE CLINICAL TRIALS.DARIOHEALTH CORP - DANCE IS ADVANCING CONVENIENT INHALABLE PRE-MEAL GLP-1 RECEPTOR AGONIST TO IMPROVE POSTPRANDIAL GLUCOSE CONTROL IN T2D PATIENTS..  Full Article

Dariohealth QTRLY Loss Per Share $0.13
Tuesday, 13 Aug 2019 

Aug 13 (Reuters) - DarioHealth Corp ::DARIOHEALTH REPORTS RESULTS FOR SECOND QUARTER 2019.Q2 REVENUE FELL 20 PERCENT TO $1.65 MILLION.ANTICIPATES HIGHER REVENUES AND REDUCED LOSSES IN SECOND HALF OF 2019.QTRLY LOSS PER SHARE $0.13.Q2 EARNINGS PER SHARE VIEW $-0.14 -- REFINITIV IBES DATA.  Full Article

Dariohealth Signs New Functional Medicine Clinic To Its Digital Diabetes Platform
Tuesday, 4 Jun 2019 

June 4 (Reuters) - DarioHealth Corp ::DARIOHEALTH SIGNS NEW FUNCTIONAL MEDICINE CLINIC TO ITS DIGITAL DIABETES PLATFORM.DARIOHEALTH CORP - ANNOUNCED AN AGREEMENT WITH FUNCTIONAL MEDICINE CENTER OF FORT COLLINS, BASED IN FORT COLLINS.  Full Article

Dariohealth Announces Pricing Of $7.2 Million Public Offering Of Common Stock
Wednesday, 22 May 2019 

May 22 (Reuters) - DarioHealth Corp ::ANNOUNCES PRICING OF $7.2 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 4.86 MILLION COMMON SHARES PRICED AT $0.60PER SHARE.  Full Article

DarioHealth Corp Reports Q4 Revenue Rose 7.7 Pct To $1.7 Mln
Monday, 25 Mar 2019 

March 25 (Reuters) - DarioHealth Corp ::DARIOHEALTH REPORTS FOURTH QUARTER AND YEAR END 2018 RECORD RESULTS.Q4 REVENUE ROSE 7.7 PERCENT TO $1.7 MILLION.NET LOSS ATTRIBUTABLE TO HOLDERS OF COMMON STOCK INCREASED BY $1.7 MILLION TO $5.0 MILLION IN Q4 OF 2018.  Full Article

DarioHealth Says Selling Stockholders May Offer Common Stock
Wednesday, 7 Nov 2018 

Nov 6 (Reuters) - DarioHealth Corp ::DARIOHEALTH CORP- SELLING STOCKHOLDERS IDENTIFIED IN PROSPECTUS MAY OFFER FROM TIME TO TIME UP TO 21.3 MILLION SHARES OF CO'S COMMON STOCK-SEC FILING.  Full Article

DarioHealth Reports Fourth Quarter And Year End 2017 Results
Monday, 19 Mar 2018 

March 19 (Reuters) - Dariohealth Corp ::DARIOHEALTH REPORTS FOURTH QUARTER AND YEAR END 2017 RESULTS.SEES FY 2018 REVENUE $8.3 MILLION TO $9.3 MILLION.SEES FY 2018 REVENUE UP AT LEAST 60 PERCENT.QUARTERLY REVENUES OF $1.6 MILLION INCREASED 88% COMPARED TO Q4 OF 2016.  Full Article

DarioHealth Says Qtrly Reports On Form 10-Q For Quarter Ended March 30, 2017, June 30, 2017 And Sept 30, 2017 Should No Longer Be Relied Upon​
Monday, 19 Mar 2018 

March 19 (Reuters) - DarioHealth Corp ::DARIOHEALTH - QTRLY REPORTS ON FORM 10-Q FOR QUARTER ENDED MARCH 30, 2017, JUNE 30, 2017 AND SEPT 30, 2017 FILED WITH SEC SHOULD NO LONGER BE RELIED UPON​.DARIOHEALTH SAYS CO'S MANAGEMENT IDENTIFIED CERTAIN ERROR RECORDED FOR RELEVANT PERIODS - SEC FILING.DARIOHEALTH - ‍ERROR RELATING TO RE-MEASUREMENT OF LIABILITY WARRANTS BEFORE RECLASSIFICATION FROM LIABILITY TO EQUITY IN PERIOD ENDED MARCH 31, 2017​.DARIOHEALTH CORP - CO TO REFLECT INCREASED NET LOSS FROM PRIOR PERIODS BUT RESTATEMENTS TO NOT HAVE IMPACT ON S STOCKHOLDER S EQUITY FOR PRIOR PERIODS​.  Full Article

Dariohealth Launches Sales Of Dario Blood Glucose Monitoring System On Amazon Prime
Tuesday, 20 Feb 2018 

Feb 20 (Reuters) - Dariohealth Corp ::DARIOHEALTH LAUNCHES SALES OF DARIO™ BLOOD GLUCOSE MONITORING SYSTEM ON AMAZON PRIME.DARIOHEALTH CORP - ‍LAUNCH AND FIRST SALES OF DARIO BLOOD GLUCOSE MONITORING SYSTEM ON AMAZON​.  Full Article